Forest Laboratories to Discontinue Namenda Tablets, Focus on Once-Daily Namenda XR

Forest Laboratories, Inc. , a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDAA 5 mg and 10 mg tablets effective August 15, 2014.

http://ift.tt/1cFMxRI